galantamine has been researched along with bay 11-7082 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emad Aboulhoda, B; Gamal, M; Magdy, S; Mohammed, HS; Rashed, L; Samir, NF; Sharawy, N | 1 |
1 other study(ies) available for galantamine and bay 11-7082
| Article | Year |
|---|---|
IκB kinase inhibition remodeled connexins, pannexin-1, and excitatory amino-acid transporters expressions to promote neuroprotection of galantamine and morphine.
Topics: Animals; Anti-Inflammatory Agents; Brain; Connexins; Disease Models, Animal; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Galantamine; Glutamic Acid; I-kappa B Kinase; Lipopolysaccharides; Male; Morphine; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroglia; Neurons; Neuroprotection; Neuroprotective Agents; Nitriles; Rats, Sprague-Dawley; Signal Transduction; Sulfones | 2021 |